Home » Reports » Smith & Nephew plc 10% Potential Upside Indicated by Credit Suisse

Smith & Nephew plc 10% Potential Upside Indicated by Credit Suisse

Smith & Nephew plc with EPIC/TICKER (LON:SN) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘NEUTRAL’ this morning by analysts at Credit Suisse. Smith & Nephew plc are listed in the Health Care sector within UK Main Market. Credit Suisse have set a target price of 1685 GBX on its stock. This would imply the analyst believes there is now a potential upside of 10.0% from today’s opening price of 1532.5 GBX. Over the last 30 and 90 trading days the company share price has increased 41 points and decreased 299.5 points respectively. The 1 year high for the stock price is 2023 GBX while the 52 week low for the stock is 1055.01 GBX.

Smith & Nephew plc has a 50 day moving average of 1,512.21 GBX and the 200 Day Moving Average price is recorded at 1,763.37. There are currently 567,962,378 shares in issue with the average daily volume traded being 2,909,608. Market capitalisation for LON:SN is £13,315,577,687 GBP.

Join us on our new LinkedIn page

Follow us on LinkedIn